Literature DB >> 35079886

Measurement of myocardial extracellular volume fraction in patients with heart failure with preserved ejection fraction using dual-energy computed tomography.

Rong-Xing Qi1,2, Jia-Shen Jiang1, Jun Shao1, Qing Zhang3, Kou-Long Zheng3, Jing Xiao4, Sheng Huang5, Shen-Chu Gong6.   

Abstract

OBJECTIVES: To measure the myocardial extracellular volume (ECV) in patients with heart failure with preserved ejection fraction (HFpEF) using dual-energy computed tomography with late iodine enhancement (LIE-DECT) and to evaluate the relationship between ECV and risk of HFpEF and cardiac structure and function.
METHODS: A total of 112 consecutive patients with HFpEF and 80 consecutive subjects without heart disease (control group) who underwent LIE-DECT were included. All patients were divided into ischaemic and non-ischaemic groups according to the LIE patterns detected using iodine maps. The ischaemic scar burden was calculated in the ischaemic HFpEF group. Iodine maps and haematocrit were used to measure ECV in the non-ischaemic HFpEF group and remote ECV of the non-scarred myocardium in the ischaemic HFpEF group, respectively. Cardiac structural and functional variables were collected.
RESULTS: ECV in patients with non-ischaemic HFpEF (n = 77) and remote ECV in patients with ischaemic HFpEF (n = 35) were significantly higher than those in control subjects (p < 0.001). Multivariate logistic regression analysis revealed that after adjusting for age, sex, body mass index, smoking, and drinking, a higher ECV/remote ECV was still associated with non-ischaemic HFpEF and ischaemic HFpEF (p < 0.001). A positive correlation was established between ECV and cardiac structural and functional variables (p < 0.05) in all participants. Subgroup analysis showed that ECV/remote ECV and ischaemic scar burden positively correlated with heart failure classification in the HFpEF subgroup (p < 0.05).
CONCLUSION: ECV/remote ECV elevation was significantly associated with non-ischaemic and ischaemic HFpEF. Remote ECV and LIE may have synergistic effects in the risk assessment of ischaemic HFpEF. KEY POINTS: • ECV/remote ECV elevation is associated not only with non-ischaemic HFpEF but also with ischaemic HFpEF. • ECV/remote ECV and ischaemic scar burden are correlated with cardiac structure and function.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Cardiac imaging techniques; Extracellular matrix; Heart failure; Left ventricular function; Tomography, x-ray computed

Mesh:

Substances:

Year:  2022        PMID: 35079886     DOI: 10.1007/s00330-021-08514-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.

Authors:  Franz Duca; Andreas A Kammerlander; Caroline Zotter-Tufaro; Stefan Aschauer; Marianne L Schwaiger; Beatrice A Marzluf; Diana Bonderman; Julia Mascherbauer
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

2.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Authors:  Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-09       Impact factor: 5.364

3.  Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis.

Authors:  Eric Y Yang; Mohamad G Ghosn; Mohammad A Khan; Nickalaus L Gramze; Gerd Brunner; Faisal Nabi; Vijay Nambi; Sherif F Nagueh; Duc T Nguyen; Edward A Graviss; Erik B Schelbert; Christie M Ballantyne; William A Zoghbi; Dipan J Shah
Journal:  Circ Cardiovasc Imaging       Date:  2019-12-16       Impact factor: 7.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.